Opendata, web and dolomites
H2020 projects about "pi3k"
The page lists 18 projects related to the topic "pi3k".
| # | |||
|---|---|---|---|
| 1 | Class II PI3K | Characterization of the signalling and physiological roles of the class II PI3Ks | 2016 |
| 2 | T6SS-PSEUDO-LIP | Type VI-dependent Pseudomonas aeruginosa phospholipases and host manipulation | 2016 |
| 3 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 4 | ChemBioAP | Elucidation of autophagy using novel chemical probes | 2016 |
| 5 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 6 | Mitomorphosis | Metabolic regulation of mitochondrial morphology | 2017 |
| 7 | TRIBBLES | Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma | 2018 |
| 8 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 9 | SAMNets | Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network | 2017 |
| 10 | PI3K-VAs | Activation of PI3K signalling in the pathogenesis of Vascular Anomalies | 2018 |
| 11 | Signalling-in-NODs | Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation | 2017 |
| 12 | Oncogenic PI3-kinase | New biology of oncogenic PI 3-kinase | 2019 |
| 13 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 |
| 14 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 15 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 16 | PI3K-in-tolerance | PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance | 2019 |
| 17 | MetaboSENS | Metabolic integration by nutrient SENSing | 2019 |
| 18 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |